Skip to content
Review Open access

Novel blood biomarkers for heart failure mortality: mechanistic pathways, aging biology, and risk stratification

Sep 2026 · Frontiers in Cardiovascular Medicine · Vol 13 · 1 citation · 118 references
Medicine

TL;DR

HF mortality may arise from the convergence of myocardial injury and systemic biological aging, and proteomic and metabolomic approaches are promising tools for identifying molecular phenotypes, although assay heterogeneity, insufficient age-specific validation, uncertain incremental clinical utility, and limited bedside interpretability remain barriers.

Abstract

Heart failure (HF) is a major global health burden associated with high mortality after decompensation, particularly in older patients with multimorbidity. Although established biomarkers such as natriuretic peptides remain essential for initial risk stratification, they capture only a fraction of mortality risk in biologically heterogeneous aging populations. Because HF-related death arises from diverse pathophysiological mechanisms, no single biomarker can capture this mechanistic diversity. This narrative review synthesizes current evidence on circulating biomarkers associated with HF mortality and maps these molecules to specific pathways of cardiac aging and systemic disease. Aging fundamentally reshapes biomarker interpretation: chronic low-grade inflammation, increased vascular stiffness, impaired organ clearance, and endocrine remodeling can alter baseline biomarker concentrations and modify the clinical significance of their longitudinal changes. The evidence reviewed here provides a rationale for a mechanism-driven, pathway-based framework rather than the pursuit of a single prognostic predictor. This framework should be regarded as conceptual and hypothesis-generating. Key biomarker domains include fibro-inflammatory remodeling and myocardial stress, represented by soluble suppression of tumorigenicity 2, galectin-3, growth differentiation factor 15, and heart-type fatty acid-binding protein, which provide overlapping information on myocardial strain, fibrosis, and systemic stress. Markers of congestion, endothelial dysfunction, and vascular aging, including carbohydrate antigen 125, bioactive adrenomedullin, mid-regional pro-adrenomedullin, and endothelin-1, may provide complementary information on hemodynamic, serosal, right-sided, and vascular stress. Markers of cardiorenal and multiorgan reserve, including neutrophil gelatinase-associated lipocalin, albumin, and composite renal or nutritional indices, highlight that HF mortality may reflect systemic vulnerability rather than isolated ventricular dysfunction. Metabolic stress and inflammation, reflected by fibroblast growth factor 21, amino-acid metabolites, and inflammatory mediators, may help characterize metabolic exhaustion and frailty trajectories. Finally, proteomic and metabolomic approaches are promising tools for identifying molecular phenotypes, although assay heterogeneity, insufficient age-specific validation, uncertain incremental clinical utility, and limited bedside interpretability remain barriers. In conclusion, HF mortality may arise from the convergence of myocardial injury and systemic biological aging. Prospective biomarker-guided studies in older, multimorbid HF populations are required before pathway-based panels can be routinely used to inform treatment and care planning.

Read PDF

Similar papers

Review Open access Oct 2026

Emerging Biomarkers in Heart Failure: Pathophysiological Mechanisms, Clinical Utility, and Multi-Omics-Driven Risk Stratification

Heart failure is a complex clinical syndrome involving neurohormonal activation, myocardial injury, inflammation, fibrosis, metabolic dysregulation, and cardiorenal dysfunction. Natriuretic peptides and cardiac troponins are established biomarkers for diagnosis and risk assessment, but they do not fully capture the...

Maryam · 0 citations
Nov 2026

Abstract P2055: Circulating Biomarkers of Myocardial Injury, Hemodynamic Stress, and Inflammation for Predicting Sudden Cardiac Death: A Meta-Analysis

Sudden cardiac death (SCD) is a leading cause of cardiovascular mortality and represents a keystone outcome in cardiovascular pathology, since it often occurs without warning. Existing risk stratification tools fail to identify many at-risk individuals. Circulating biomarkers reflecting myocardial injury, hemodynamic...

Kristina Tomanov, Maya Achettu, Smira Sonthalia · 0 citations
Open access Sep 2026

Beyond Ejection Fraction: Inflammatory Risk and Mortality in Heart Failure

A higher systemic inflammatory burden was independently associated with recorded all-cause mortality across the spectrum of heart failure spectrum, and its incremental value appears modest.

B. Krastev, N. Spasova, D. Somleva et al. · 1 citation
Open access Oct 2026

Sex-specific phenotypes, biomarkers, and outcomes in chronic heart failure: insights from a contemporary cohort of women

Sex-related differences in chronic heart failure (CHF) remain insufficiently characterized, particularly regarding phenotypic heterogeneity, biomarker profiles, and prognostic determinants. Women with CHF often present with distinct cardiometabolic comorbidities, preserved or mildly reduced ejection fraction, and...

D. Abidova, Jamol Uzokov · 0 citations
Review Open access Oct 2026

Circulating biomarkers linking heart failure and chronic obstructive pulmonary disease: Toward an integrated biological framework - A systematic review.

Heart failure (HF) and chronic obstructive pulmonary disease (COPD) frequently coexist and are associated with substantial morbidity, mortality, and healthcare utilization. Accumulating evidence suggests that these conditions also share biological mechanisms that contribute to disease progression. However, although num...

L. Corneanu, O. Petriș, V. Șorodoc et al. · 0 citations
Review Open access Oct 2026

Cardiovascular Risk Factors and Biomarkers in the Prediction of Cognitive Decline in Older Adults—A Narrative Review

Background: Cognitive decline is a major health concern in older adults and results from a complex interaction between neurodegenerative, vascular, metabolic and inflammatory processes. Cardiovascular and metabolic risk factors may contribute to cognitive impairment through mechanisms including endothelial dysfunction,...

Diana-Gabriela Constantinescu, A. Ilie, Ramona Ștefăniu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.